621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC).
Saved in:
| Title: | 621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC). |
|---|---|
| Authors: | Modi, S.1 (AUTHOR), Ates, O.2 (AUTHOR), Baird, R.D.3 (AUTHOR), Bulat, I.V.4 (AUTHOR), Moreno Candilejo, I.5 (AUTHOR), Curigliano, G.6 (AUTHOR), Dalenc, F.7 (AUTHOR), Jerzak, K.8 (AUTHOR), Maglakelidze, M.9 (AUTHOR), Savas, P.10 (AUTHOR), Wenger, M.11 (AUTHOR), Brück, P.11 (AUTHOR), Munshi, N.12 (AUTHOR), Guo, Z.13 (AUTHOR), Qiu, Y.14 (AUTHOR), Mu, H.14 (AUTHOR), Türeci, Ö.15 (AUTHOR), Sahin, U.16 (AUTHOR), Shao, Z-M.17 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS465-S465. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189418879 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Modi%2C+S%2E%22">Modi, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ates%2C+O%2E%22">Ates, O.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baird%2C+R%2ED%2E%22">Baird, R.D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bulat%2C+I%2EV%2E%22">Bulat, I.V.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moreno+Candilejo%2C+I%2E%22">Moreno Candilejo, I.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Curigliano%2C+G%2E%22">Curigliano, G.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dalenc%2C+F%2E%22">Dalenc, F.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jerzak%2C+K%2E%22">Jerzak, K.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maglakelidze%2C+M%2E%22">Maglakelidze, M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Savas%2C+P%2E%22">Savas, P.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wenger%2C+M%2E%22">Wenger, M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brück%2C+P%2E%22">Brück, P.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Munshi%2C+N%2E%22">Munshi, N.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Z%2E%22">Guo, Z.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qiu%2C+Y%2E%22">Qiu, Y.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mu%2C+H%2E%22">Mu, H.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Türeci%2C+Ö%2E%22">Türeci, Ö.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sahin%2C+U%2E%22">Sahin, U.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shao%2C+Z-M%2E%22">Shao, Z-M.</searchLink><relatesTo>17</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS465-S465. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189418879 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.1043 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S465 Titles: – TitleFull: 621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Modi, S. – PersonEntity: Name: NameFull: Ates, O. – PersonEntity: Name: NameFull: Baird, R.D. – PersonEntity: Name: NameFull: Bulat, I.V. – PersonEntity: Name: NameFull: Moreno Candilejo, I. – PersonEntity: Name: NameFull: Curigliano, G. – PersonEntity: Name: NameFull: Dalenc, F. – PersonEntity: Name: NameFull: Jerzak, K. – PersonEntity: Name: NameFull: Maglakelidze, M. – PersonEntity: Name: NameFull: Savas, P. – PersonEntity: Name: NameFull: Wenger, M. – PersonEntity: Name: NameFull: Brück, P. – PersonEntity: Name: NameFull: Munshi, N. – PersonEntity: Name: NameFull: Guo, Z. – PersonEntity: Name: NameFull: Qiu, Y. – PersonEntity: Name: NameFull: Mu, H. – PersonEntity: Name: NameFull: Türeci, Ö. – PersonEntity: Name: NameFull: Sahin, U. – PersonEntity: Name: NameFull: Shao, Z-M. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |